Insider trades

Adam M. Veness, SVP of Dianthus Therapeutics DNTH, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/17.

Adam M. Veness

SVP, General Counsel and Sec
First filing
23/02/07
Trades
9 trades
Buys / sales
0 / 2
12-month net buying
−$2.4M
Last trade
06/17

Trading activity

Transactions

Trade type
DNTH
Open-market sale10b5-1 plan06/1706/1830,000 sh2 trades$80.80avg.$2,423,958.16−100.0%